Skip to content

Chemed CHE Additional Paid-In Capital

Additional Paid-In Capital at other companies

MYR Group logo
MYR GroupMYRG
$162.37M+6.2%
Piper Sandler logo
Piper SandlerPIPR
$1B+1.7%
Repligen logo
RepligenRGEN
$1.65B+2.2%
LKQ logo
LKQLKQ
$1.58B+1.7%
ST
Sensata TechnologiesST
$1.9B+1.3%
CHE
ChemedCHE
$1.6B+4.2%

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's additional paid-in capital?
Chemed (CHE) reported additional paid-in capital of $1.6B in Q1 2026.
How has Chemed's additional paid-in capital changed year-over-year?
Chemed's additional paid-in capital increased by 4.2% year-over-year, from $1.54B to $1.6B.
What is the long-term trend for Chemed's additional paid-in capital?
Over 5 years (2020 to 2025), Chemed's additional paid-in capital has grown at a 10.6% compound annual growth rate (CAGR), from $961.4M to $1.59B.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.